MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-10-2025
Myomo Retained Earnings 2011-2026 | MYO
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Myomo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -88.8 M | -78.1 M | -67.7 M | -56.1 M | -45.3 M | -35 M | -22.9 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -22.9 M | -88.8 M | -56.3 M |
Quarterly Retained Earnings Myomo
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -115 M | -111 M | -107 M | -103 M | -103 M | -102 M | -101 M | -96.9 M | -94.5 M | -92.4 M | -91.4 M | -88.8 M | -86.6 M | - | -80.9 M | -78.1 M | -75.3 M | -73.3 M | -70.7 M | -67.7 M | -67.7 M | -67.7 M | -67.7 M | -56.1 M | -56.1 M | -56.1 M | -56.1 M | -45.3 M | -45.3 M | -45.3 M | -45.3 M | -35 M | -35 M | -35 M | -35 M | -22.9 M | -22.9 M | -22.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -22.9 M | -115 M | -69.1 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 12.4 | -4.65 % | $ 1.86 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 38.94 | 1.13 % | $ 5.8 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.23 | 0.44 % | $ 591 M |  Israel |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 9.54 | -1.4 % | $ 1.29 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 24.13 | -0.66 % | $ 204 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 41.94 | -2.45 % | $ 1.3 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.16 | -2.24 % | $ 155 M |  France |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.47 | -0.35 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 28.9 | -1.1 % | $ 1.33 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.29 | -0.3 % | $ 114 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.51 | -2.45 % | $ 52.4 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.81 | 1.9 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 176.85 | -2.92 % | $ 13.2 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 3.65 | -9.55 % | $ 773 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 111.33 | -1.52 % | $ 194 B | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.44 | -0.88 % | $ 869 M | Israel |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 71.54 | -0.93 % | $ 106 B | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 100.56 | -4.33 % | $ 1.27 B | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.41 | -0.01 % | $ 22.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.4 | -5.84 % | $ 408 M | USA |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.62 | 12.5 % | $ 63.4 M | USA |
 |
Medtronic PLC
MDT
|
31.5 B | $ 92.72 | -3.01 % | $ 119 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.23 | -3.46 % | $ 1.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 83.86 | -1.6 % | $ 49 B | USA |